Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patients

Launched by SICHUAN CANCER HOSPITAL AND RESEARCH INSTITUTE · Jan 5, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on developing a new tool designed to assess the health and needs of older adults with cancer. The researchers aim to create a comprehensive screening tool that helps doctors evaluate important aspects of a patient's health, which can influence their cancer treatment. They will start by identifying the best questions to include in the tool, then test it with actual patients to make sure it is clear and effective. The goal is to ensure that this tool will reliably support doctors in making better decisions about patient care, especially for those aged 65 and older.

To be eligible for this study, participants must be at least 65 years old, diagnosed with a cancer that is being treated at the hospital, and willing to take part in the research. Throughout the study, participants can expect to undergo assessments that evaluate their health and how it relates to their cancer treatment. The researchers will also follow up with participants to see how well the tool predicts treatment outcomes and any potential side effects. This trial is currently not recruiting participants yet, but it promises to improve the way healthcare providers support older cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥ 65 years old
• • 2. There are clear pathological data to diagnose malignant tumors, and follow-up anti-tumor therapy is determined in this institution
• • 3. Have a certain enthusiasm for this study, and voluntarily participate in this study
• Exclusion Criteria:
• • 1. Unable to understand the content of the research
• • 2. Unable to cooperate with CGA and screening assessments